SCHEMBL30148426

SCHEMBL30148426

S=C=Nc1ccccn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1477433 1.00
Hydrochloric Acid SCHEMBL10416679 0.98 ADRA2A (0.48)
SCHEMBL3275986 0.81 ADRA2A (0.50)
SCHEMBL30384637 0.77
SCHEMBL9095841 0.77
SCHEMBL9095842 0.77
SCHEMBL8916413 0.77
SCHEMBL708434 0.77
Water SCHEMBL28118014 0.76 ADRA2A (0.45)
Fluoride SCHEMBL28035044 0.76 ADRA2A (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12018021-B2 Thiophene derivatives for the treatment of disorders caused by IgE UCB Biopharma SRL (BE) 2024-06-25 US disclosed
US-20220332709-A1 Thiophene derivatives for the treatment of disorders caused by IgE UCB Biopharma SRL (BE) 2022-10-20 US disclosed